![Edward F. Patz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Edward F. Patz
Sociétés | Poste | Début | Fin |
---|---|---|---|
Grid Therapeutics LLC
![]() Grid Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Grid Therapeutics LLC develops and research cancer therapeutics to develop human derived antibodies. Its pipeline drugs include GT103 recombinant complement factor H monoclonal antibody and GT-20(x) recombinant monoclonal antibody. The company was founded by Edward F. Patz, Jr., Michael John Campagna and Elizabeth B. Gottlin and is headquartered in Chapel Hill, NC. | Directeur/Membre du Conseil | - | - |
Directeur Général | 01/09/2016 | - | |
Fondateur | - | - |
Historique de carrière de Edward F. Patz
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Grid Therapeutics LLC
![]() Grid Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Grid Therapeutics LLC develops and research cancer therapeutics to develop human derived antibodies. Its pipeline drugs include GT103 recombinant complement factor H monoclonal antibody and GT-20(x) recombinant monoclonal antibody. The company was founded by Edward F. Patz, Jr., Michael John Campagna and Elizabeth B. Gottlin and is headquartered in Chapel Hill, NC. | Commercial Services |
- Bourse
- Insiders
- Edward F. Patz
- Expérience